Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated

Differential Diagnosis and the Indomethacin Test

At a Glance

Paroxysmal hemicrania is distinguished from similar one-sided headaches by short, frequent attacks and complete relief between them. A supervised indomethacin trial should stop the attacks completely; partial relief usually prompts reconsideration of the diagnosis or evaluation for another cause.

When you have severe, one-sided head pain, getting the right diagnosis can be difficult because several conditions look very similar. Doctors group these together as Trigeminal Autonomic Cephalalgias (TACs) [1]. To tell them apart, your medical team looks at two things: the “stopwatch” (how long the pain lasts) and the “Indo-test” (how the pain reacts to a specific medication) [2][3].

The “Stopwatch” Test: Differentiating TACs

The most important clue in diagnosing Paroxysmal Hemicrania (PH) is the timing and frequency of the attacks. PH lives in a “middle ground” between other types of headaches:

  • PH vs. Cluster Headache: Cluster headaches are often called the “big brother” of PH. However, Cluster Headache attacks are much longer—usually lasting between 15 and 180 minutes—and happen less frequently (up to 8 times a day) [2][4]. PH attacks are shorter (2 to 30 minutes) and happen much more often [1].
  • PH vs. SUNCT/SUNA: These conditions involve incredibly brief “stabs” of pain that last only seconds to a few minutes [5][6]. They can happen hundreds of times a day and are often triggered by touching the face or washing your hair, which is less common in PH [5].
  • PH vs. Hemicrania Continua: While both respond to the same medication, Hemicrania Continua (HC) involves a continuous, 24/7 background ache that never goes away, even when the sharp “spikes” of pain aren’t happening [7][8]. In PH, there is typically a period of total, 100% relief between attacks [1].

The Indomethacin Test (The “Indo-Test”)

The “gold standard” for confirming a PH diagnosis is a diagnostic trial of a medication called indomethacin [1][3]. It is a potent NSAID (non-steroidal anti-inflammatory drug), and while its precise mechanism in PH remains uncertain, its distinct clinical response is diagnostically useful [9].

How the Test Works

Your doctor will likely prescribe a specific “trial” dose. For example, some specialists might start an adult trial at 25 mg taken three times a day [10]. If there is no response, the dose may be increased gradually—sometimes up to 75 mg or even 150 mg per day to ensure the test is thorough [11][12]. These are strictly clinician-directed examples; never start, increase, or repeat a trial without a prescriber.

What a “Complete Response” Means

In the world of PH, “complete” means absolute [1].

  • A Positive Result: The headache attacks vanish entirely, sometimes within 24 to 48 hours of reaching the correct dose, while others respond later during a supervised titration [10][13].
  • A Negative Result: If the pain does not stop completely at a therapeutic dose, the diagnosis of PH is usually reconsidered, though a negative result can also reflect inadequate dose, poor absorption, or intolerance [1].

Why a “Partial Response” Matters

It is a common misconception that if a headache “gets better” with indomethacin, it must be PH. However, many types of headaches (including some migraines) might feel a little better after taking a strong anti-inflammatory [12].

For a formal diagnosis of Paroxysmal Hemicrania, the response must be absolute [1][14]. If your attacks become less frequent or less intense, but do not stop entirely, your doctor will likely reconsider your diagnosis and may investigate other causes, such as Cluster Headache or a “secondary” headache caused by another underlying issue [1][15]. Because high-dose indomethacin can be hard on the stomach and kidneys, doctors want to be certain of the diagnosis before committing to long-term treatment [16][17].

Common questions in this guide

How is paroxysmal hemicrania different from cluster headache?
Paroxysmal hemicrania attacks usually last 2 to 30 minutes and occur more often. Cluster headache attacks usually last 15 to 180 minutes and occur up to eight times a day. Attack duration and frequency help clinicians tell them apart.
What does a complete response to indomethacin mean?
A complete response means the attacks stop entirely after the prescribed dose is reached, rather than simply becoming milder or less frequent. This strong response supports a diagnosis of paroxysmal hemicrania.
Does partial relief from indomethacin confirm paroxysmal hemicrania?
No. Many headaches can improve somewhat with an anti-inflammatory, so partial relief is not the complete response expected for paroxysmal hemicrania. The clinician may reconsider the diagnosis, check whether the trial was adequate, or investigate another cause.
How quickly should indomethacin work during a diagnostic trial?
Some people have complete relief within 24 to 48 hours of reaching the correct dose, while others respond later during a clinician-supervised dose increase. Your prescriber should decide how long the trial continues and whether the result is meaningful.
What should I know about indomethacin if I have stomach ulcers or acid reflux?
Indomethacin can be hard on the stomach and kidneys, particularly at higher doses. If you have ulcers or acid reflux, ask your prescriber how to perform the trial safely, and never change the dose on your own.
How can doctors distinguish paroxysmal hemicrania from hemicrania continua?
Both conditions can respond to indomethacin, but hemicrania continua causes a continuous background ache with pain spikes. Paroxysmal hemicrania typically has complete relief between attacks.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Paroxysmal hemicrania.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If my pain only gets 50% better on indomethacin, what does that mean for my diagnosis?
  2. 2.What is the specific dosage schedule you want me to follow for the 'Indo-test'?
  3. 3.How long should I wait for a response before we decide the test was unsuccessful?
  4. 4.If I have a history of stomach ulcers or acid reflux, how can we safely perform this diagnostic trial?
  5. 5.Is it possible for me to have both PH and another type of headache at the same time?

References

References (17)
  1. 1

    Paroxysmal Hemicrania: An Update.

    Paliwal VK, Uniyal R

    Neurology India 2021; (69(Supplement)):S135-S143 doi:10.4103/0028-3886.315982.

    PMID: 34003159
  2. 2

    Trigeminal Autonomic Cephalalgias in Children and Adolescents: Cluster Headache and Related Conditions.

    Mack KJ, Goadsby P

    Seminars in pediatric neurology 2016; (23(1)):23-6.

    PMID: 27017018
  3. 3

    Cluster Headache and Other Trigeminal Autonomic Cephalalgias.

    Burish M

    Continuum (Minneapolis, Minn.) 2018; (24(4, Headache)):1137-1156 doi:10.1212/CON.0000000000000625.

    PMID: 30074553
  4. 4

    Managing cluster headache.

    Wei DY, Khalil M, Goadsby PJ

    Practical neurology 2019; (19(6)):521-528 doi:10.1136/practneurol-2018-002124.

    PMID: 31278205
  5. 5

    SUNCT, SUNA and short-lasting unilateral neuralgiform headache attacks: Debates and an update.

    Kang MK, Cho SJ

    Cephalalgia : an international journal of headache 2024; (44(2)):3331024241232256 doi:10.1177/03331024241232256.

    PMID: 38415675
  6. 6

    SUNCT and SUNA: An Update.

    Duggal AK, Chowdhury D

    Neurology India 2021; (69(Supplement)):S144-S159 doi:10.4103/0028-3886.315990.

    PMID: 34003160
  7. 7

    Overview of Trigeminal Autonomic Cephalalgias: Nosologic Evolution, Diagnosis, and Management.

    Wei DY, Yuan Ong JJ, Goadsby PJ

    Annals of Indian Academy of Neurology 2018; (21(Suppl 1)):S39-S44 doi:10.4103/aian.AIAN_348_17.

    PMID: 29720817
  8. 8

    Hemicrania continua: clinical review, diagnosis and management.

    Prakash S, Patel P

    Journal of pain research 2017; (10()):1493-1509 doi:10.2147/JPR.S128472.

    PMID: 28721092
  9. 9

    Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment.

    Bahra A

    Cephalalgia : an international journal of headache 2023; (43(11)):3331024231214239 doi:10.1177/03331024231214239.

    PMID: 37950675
  10. 10

    Menstruation-triggered paroxysmal hemicrania.

    Patel S, Shah H, Prakash S

    BMJ case reports 2026; (19(8)) doi:10.1136/bcr-2026-274651.

    PMID: 42618320
  11. 11

    Paroxysmal hemicrania: A diagnostic challenge presenting as orofacial pain: A case series.

    Al-Taee A, Botros J, Groenke BR, Nixdorf DR

    Cranio : the journal of craniomandibular practice 2026; (44(4)):721-728 doi:10.1080/08869634.2025.2610489.

    PMID: 41456204
  12. 12

    Indomethacin Responsive Headaches: Exhaustive Systematic Review with Pooled Analysis and Critical Appraisal of 81 Published Clinical Studies.

    Bordini EC, Bordini CA, Woldeamanuel YW, Rapoport AM

    Headache 2016; (56(2)):422-35 doi:10.1111/head.12771.

    PMID: 26853085
  13. 13

    Case Report: Shortest Course of Pediatric Paroxysmal Hemicrania.

    Ishii R, Fukazawa R, Takezawa H, Fujii A

    Headache 2019; (59(7)):1084-1087 doi:10.1111/head.13580.

    PMID: 31264201
  14. 14

    Paroxysmal Hemicrania.

    Osman C, Bahra A

    Annals of Indian Academy of Neurology 2018; (21(Suppl 1)):S16-S22 doi:10.4103/aian.AIAN_317_17.

    PMID: 29720814
  15. 15

    Indomethacin-Responsive Headache Disorders.

    Goadsby PJ

    Continuum (Minneapolis, Minn.) 2024; (30(2)):488-497 doi:10.1212/CON.0000000000001409.

    PMID: 38568495
  16. 16

    The spectrum of indomethacin-responsive headaches in children and adolescents.

    Myers KA, Barmherzig R, Raj NR, et al.

    Cephalalgia : an international journal of headache 2022; (42(8)):793-797 doi:10.1177/03331024221076483.

    PMID: 35302385
  17. 17

    How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?

    Osiowski A, Stolarz K, Taterra D

    Current opinion in neurology 2025; (38(3)):254-261 doi:10.1097/WCO.0000000000001347.

    PMID: 39911098

This page explains how clinicians distinguish paroxysmal hemicrania from similar headaches and use an indomethacin trial for informational purposes only. It does not constitute medical advice; follow dosing and safety instructions from your prescriber.